background image

Fatty Liver Clinical Trials

Find clinical trials for Fatty Liver. Search for Fatty Liver clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

Fibrosis Lessens After Metabolic Surgery

for
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD),
Location: Cleveland OH
Sponsor: Ali Aminian

Sex: All

Age: 18 - 70+

Code: NCT06374875

Recruiting
Active & Responsive

Congenital Muscle Disease Study of Patient and Family Reported Medical Information

for
Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency,
Location: Lakewood CA
Sponsor: Cure CMD

Sex: All

Age: 0+

Code: NCT01403402

Recruiting
Active & Responsive

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)

for
Obesity, Non-Alcoholic Fatty Liver Disease,
Location: Columbia MO
Sponsor: Bettina Mittendorfer

Sex: All

Age: 18 - 70

Code: NCT06571474

Recruiting
Active & Responsive

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease,
Location: Seattle WA
Sponsor: ContextVision AB

Sex: All

Age: 18 - 70+

Code: NCT07270601

Recruiting
Active & Responsive

Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)

for
Hepatic Steatosis, NAFLD, Adolescent Obesity
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 13 - 18

Code: NCT05935826

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD

for
Metabolic Dysfunction-Associated Steatotic Liver Disease,
Location: Boardman OH
Sponsor: Seoul National University Hospital

Sex: All

Age: 18+

Code: NCT07192159

Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: Birmingham AL, Dothan AL, Chandler AZ, Peoria AZ,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase3, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: Birmingham AL, Dothan AL, Chandler AZ, Mesa AZ,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase3, Recruiting
Active & Responsive

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

for
Parenteral Nutrition Associated Liver Disease (PNALD),
Location: Fountain Valley CA, Los Angeles CA, Chicago IL,
Sponsor: Fresenius Kabi

Sex: All

Age: 0 - 17

Code: NCT06274788

Recruiting
New

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

for
Non-alcoholic Fatty Liver Disease
Location: Miami FL, Ocala FL, St Louis MO, San Antonio TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70+

Code: NCT07221188

Phase3, Recruiting